regulatory approval

123 articles
The Motley FoolThe Motley Fool··Jack Delaney

NuScale Power Stock Plunges 70% as Nuclear Startup Races Against Market Skepticism

NuScale Power stock crashed 70% in six months despite government interest in space nuclear reactors. The unprofitable SMR company faces skepticism over commercialization timelines.
SMRnuclear energydata centers
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inspired Entertainment Gains Alberta iGaming License, Bolsters North American Expansion

Inspired Entertainment secures Alberta iGaming supplier registration, positioning itself to serve the province's regulated online casino and sports betting market launching Q3 2026.
INSEsports bettingregulatory approval
BenzingaBenzinga··Evette Mitkov

Enveric Surges 106% on Trump's Psychedelics Push, but Downtrend Lingers

$ENVB surges 106% after Trump orders federal acceleration of psychedelic treatment approvals and commits $50M to ibogaine research, though stock remains deeply depressed technically.
ENVBbiotechregulatory approval
GlobeNewswire Inc.GlobeNewswire Inc.··Perspective Therapeutics, Inc.

Perspective Therapeutics Advances Rare Cancer Therapy With 43% Response Rate Data

Perspective Therapeutics reports 43% response rate for neuroendocrine tumor therapy with no serious safety issues, planning 2026 regulatory submissions.
CATXclinical trialcancer treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Pepeto Raises $9.2M as XRP Targets $10 Amid Bullish Crypto Momentum

Pepeto DeFi project secures $9.2M presale funding ahead of Binance listing. XRP shows bullish momentum with $8-$10 price targets amid ETF inflows.
SCBFYXRPCXRP price predictionregulatory approval
The Motley FoolThe Motley Fool··Keith Noonan

TMC Stock Rallies on Regulatory Tailwinds Despite Year-to-Date Losses

TMC gains retail investor bullish sentiment after NOAA indicates substantial regulatory compliance, positioning permits within 12 months despite year-to-date losses.
TMCTMCWWcritical mineralscommercialization
BenzingaBenzinga··Vandana Singh

MeiraGTx Reacquires Eye Disease Drug From J&J for $25M, Eyes 2027 Launch

MeiraGTx reacquires J&J's eye disease drug bota-vec for $25M, raises $100M in funding, targeting 2027 launch. Stock falls 15.8%.
JNJLLYMGTXcapital raiseregulatory approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bavarian Nordic's Chikungunya Vaccine Wins Swiss Approval, Expanding Global Market Access

Bavarian Nordic's chikungunya vaccine VIMKUNYA wins Swiss regulatory approval, marking the fourth major authorization in 2025 following FDA, EMA, and MHRA clearances.
BVNRYregulatory approvalinfectious disease
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Terra Innovatum Eyes April Update as Nuclear Microreactor Firm Completes 2025 Filing

Terra Innovatum ($NKLR) schedules April 16 business update as it completes 2025 Form 10-K filing, discussing regulatory progress and commercial development for its SOLO™ Micro-Modular Reactor.
NKLRnuclear powerregulatory approval
The Motley FoolThe Motley Fool··John Ballard

Coinbase's Volatility Bets Against PayPal's Stability in Crypto-Finance Showdown

Coinbase's volatile crypto-tied revenue outperformed stable PayPal since 2023, reflecting divergent bets on cryptocurrency's future as regulatory clarity looms.
COINPYPLfintechstock performance
BenzingaBenzinga··Vandana Singh

Stereotaxis Bets Billions on Robocath Takeover to Dominate Robotic Cardiology

Stereotaxis acquires Robocath for $20M upfront plus $25M in milestones, targeting $2M first-year revenue and breakeven by year three.
STXSacquisitionregulatory approval
The Motley FoolThe Motley Fool··Joe Tenebruso

Amazon's $11B Globalstar Deal Signals Aggressive Space Race Push Against SpaceX

Amazon acquires Globalstar for $11B to build satellite internet network rivaling SpaceX's Starlink, with Apple as key partner.
AMZNAAPLGSATacquisitionregulatory approval
BenzingaBenzinga··Akanksha Bakshi

AAL Stock Surges on Merger Whispers, but Antitrust Hurdles Loom Large

American Airlines shares jumped 8.24% on merger speculation with United Airlines, though legal experts doubt regulatory approval would materialize.
UALAALJETStechnical analysismerger
GlobeNewswire Inc.GlobeNewswire Inc.··Ataibeckley Inc.

AtaiBeckley CEO to Present at Needham Conferences as Psychedelic Drug Advances

AtaiBeckley will showcase its FDA-designated breakthrough therapy BPL-003 at Needham conferences in April, advancing toward Phase 3 trials in 2026.
ATAItreatment-resistant depressionFDA Breakthrough Therapy Designation
BenzingaBenzinga··Globe Newswire

AtlasClear Advances Commercial Bancorp Acquisition With Regulatory Filings

AtlasClear Holdings files regulatory applications to acquire Commercial Bancorp parent of Farmers State Bank, structured with 73% stock and 27% cash consideration pending Federal Reserve and Wyoming approvals.
ATCHacquisitionM&A
BenzingaBenzinga··Na

Regional Banks $BHRB and $LNKB Clear Regulatory Hurdles, Set May 2026 Merger Close

$BHRB and $LNKB receive all regulatory approvals for merger, confirming May 1, 2026 closing date subject to customary conditions.
BHRBLNKBmergerbanking
The Motley FoolThe Motley Fool··Steven Porrello

Deep-Sea Mining Bet: TMC Metals Could Yield Massive Returns if Regulators Approve

TMC The Metals Company trades 50% below recent highs while awaiting commercial mining permits. Regulatory approval within 12 months could unlock significant upside from deep-sea polymetallic nodules.
TMCTMCWWcritical mineralsregulatory approval
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Deep-Sea Mining Gets Political Push, but $TMC Investors Face Years of Losses Ahead

The Metals Company gains regulatory approval and U.S.-Japan cooperation backing, but remains unprofitable with revenue years away.
TMCTMCWWcritical mineralsregulatory approval
BenzingaBenzinga··Prnewswire

Catalyst Bancorp to Acquire Lakeside Bancshares in $41.1M All-Cash Deal

Catalyst Bancorp acquires Lakeside Bancshares for $41.1M in all-cash deal, creating $627.3M asset bank with 180%+ EPS accretion potential.
CLSTLKSBacquisitionmerger
Investing.comInvesting.com··Ryan Hasson

Rocket Lab Cleared to Acquire Mynaric: A Bold Bet on Satellite Communications

Rocket Lab wins German regulatory approval to acquire Mynaric, a laser-communications provider, in a transformative move toward vertical integration. Stock rallies 10%.
RKLBsupply chainvertical integration